Search research articles
Contact Us
Filters
Showing results (61-70 of 283) with videos related to
Page
of 29
Sort By:
Alzheimer'S Research & Therapy
|
September 30, 2020
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
Giovanni Bellomo, Samuela Cataldi, Silvia Paciotti, et al.
Clinical Chemistry and Laboratory Medicine
|
September 1, 2023
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa<sup>®</sup> assays targeting distinct amyloid regions
Anna Lidia Wojdała, Giovanni Bellomo, Andrea Toja, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|
July 13, 2006
Risk factors and stroke subtypes: results of five consecutive years of the Perugia Stroke Registry
Giorgio Silvestrelli, Maurizio Paciaroni, Valeria Caso, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|
November 27, 2002
The Perugia hospital-based Stroke Registry: report of the 2nd year
Giorgio Silvestrelli, Francesco Corea, Maurizio Paciaroni, et al.
Nature Communications
|
January 3, 2025
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer's disease biomarkers
Anna L Wojdała, Giovanni Bellomo, Lorenzo Gaetani, et al.
Journal of Neurology
|
February 17, 2025
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective
Elena Di Sabatino, Diana Ferraro, Lorenzo Gaetani, et al.
Applied Neuropsychology. Adult
|
June 21, 2017
Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment
Federica Cacciamani, Nicola Salvadori, Paolo Eusebi, et al.
Journal of Neurology
|
May 9, 2003
Selection of thrombogenetic antiphospholipid antibodies in cerebrovascular disease patients
Valeria Caso, Lucilla Parnetti, Paolo Panarelli, et al.
Journal of Alzheimer'S Disease : JAD
|
October 9, 2010
CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease
Davide Chiasserini, Lucilla Parnetti, Ulf Andreasson, et al.
Journal of Neurology
|
March 9, 2023
Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer's disease: an expert opinion and practical guideline
Massimo Filippi, Giordano Cecchetti, Annachiara Cagnin, et al.
Page
of 29
Search research articles
Search
Showing results (61-70 of 283) with videos related to
Sort By:
Page
of 29
Alzheimer'S Research & Therapy
|
September 30, 2020
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: do fresh vs frozen samples differ?
Giovanni Bellomo, Samuela Cataldi, Silvia Paciotti, et al.
Clinical Chemistry and Laboratory Medicine
|
September 1, 2023
CSF and plasma Aβ42/40 across Alzheimer's disease continuum: comparison of two ultrasensitive Simoa<sup>®</sup> assays targeting distinct amyloid regions
Anna Lidia Wojdała, Giovanni Bellomo, Andrea Toja, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|
July 13, 2006
Risk factors and stroke subtypes: results of five consecutive years of the Perugia Stroke Registry
Giorgio Silvestrelli, Maurizio Paciaroni, Valeria Caso, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)
|
November 27, 2002
The Perugia hospital-based Stroke Registry: report of the 2nd year
Giorgio Silvestrelli, Francesco Corea, Maurizio Paciaroni, et al.
Nature Communications
|
January 3, 2025
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer's disease biomarkers
Anna L Wojdała, Giovanni Bellomo, Lorenzo Gaetani, et al.
Journal of Neurology
|
February 17, 2025
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective
Elena Di Sabatino, Diana Ferraro, Lorenzo Gaetani, et al.
Applied Neuropsychology. Adult
|
June 21, 2017
Evidence of practice effect in CANTAB spatial working memory test in a cohort of patients with mild cognitive impairment
Federica Cacciamani, Nicola Salvadori, Paolo Eusebi, et al.
Journal of Neurology
|
May 9, 2003
Selection of thrombogenetic antiphospholipid antibodies in cerebrovascular disease patients
Valeria Caso, Lucilla Parnetti, Paolo Panarelli, et al.
Journal of Alzheimer'S Disease : JAD
|
October 9, 2010
CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease
Davide Chiasserini, Lucilla Parnetti, Ulf Andreasson, et al.
Journal of Neurology
|
March 9, 2023
Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer's disease: an expert opinion and practical guideline
Massimo Filippi, Giordano Cecchetti, Annachiara Cagnin, et al.
Page
of 29